Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “S-1”

411 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 411 results

Testing effectiveness (Phase 2)Study completedNCT02558868
What this trial is testing

Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Zhejiang University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06396585
What this trial is testing

The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Immunotherapy Gastroesophageal Junction
Fujian Cancer Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01286766
What this trial is testing

Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer
Yonsei University 6
Testing effectiveness (Phase 2)UnknownNCT02913066
What this trial is testing

S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Mianyang Central Hospital 88
Testing effectiveness (Phase 2)UnknownNCT01542294
What this trial is testing

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 71
Testing effectiveness (Phase 2)UnknownNCT02634502
What this trial is testing

Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis

Who this might be right for
Carcinoma, Pancreatic
Fudan University 30
Testing effectiveness (Phase 2)WithdrawnNCT03843853
What this trial is testing

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
The First Affiliated Hospital with Nanjing Medical University
Testing effectiveness (Phase 2)UnknownNCT01533324
What this trial is testing

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
CarcinomaLiver DiseasesHepatocellular Carcinoma
Second Military Medical University 32
Testing effectiveness (Phase 2)UnknownNCT03986294
What this trial is testing

Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT05026905
What this trial is testing

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Who this might be right for
Phase II, Open-label, Parallel 2-arm, Multi-center
National Health Research Institutes, Taiwan 66
Testing effectiveness (Phase 2)UnknownNCT00209651
What this trial is testing

Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 40
Not applicableUnknownNCT05566119
What this trial is testing

L5-S1 Disc Fate in Thoracolumbar Arthrodesis Stopping at L5

Who this might be right for
Spinal Deformity
Fondation Hôpital Saint-Joseph 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05773092
What this trial is testing

Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC

Who this might be right for
NSCLC
National Cancer Centre, Singapore 30
Testing effectiveness (Phase 2)UnknownNCT02223611
What this trial is testing

Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection

Who this might be right for
Non-small Cell Lung Cancer Stage ⅡNon-small Cell Lung Cancer Stage ⅢA
Hebei Medical University Fourth Hospital 100
Large-scale testing (Phase 3)Study completedNCT04209400
What this trial is testing

Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®

Who this might be right for
Hepatitis B
VBI Vaccines Inc. 100
Testing effectiveness (Phase 2)UnknownNCT00134095
What this trial is testing

S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer

Who this might be right for
Gastric Cancer
Fukushima Medical University Hospital 70
Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06662877
What this trial is testing

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

Who this might be right for
Biliary Tract CancerSecond Line TreatmentChemotherapy+1 more
Sun Yat-sen University 206
Not applicableUnknownNCT04889768
What this trial is testing

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery
Zhejiang Cancer Hospital 46
Early research (Phase 1)Study completedNCT00663741
What this trial is testing

Sorafenib Gastric Cancer Asian Phase I Study

Who this might be right for
Gastric Cancer
Bayer 13
Load More Results